Philips and Isala Hospital Extend Partnership to Boost Healthcare Innovation and Sustainability

Philips and Isala Hospital Extend Partnership to Boost Healthcare Innovation and Sustainability

(IN BRIEF) Philips and Isala Hospital have renewed their strategic partnership to enhance healthcare delivery through advanced technology, focusing on radiology and cardiology. The collaboration, which began in 2012, will continue for five years with an option to extend. The partnership aims to keep healthcare accessible, available, and affordable by integrating cutting-edge technology and AI. Isala will also modernize its medical systems, ensuring sustainability and cost-effectiveness.

(PRESS RELEASE) AMSTERDAM, 13-Aug-2024 — /EuropaWire/ — Philips and Isala Hospital have recently announced the renewal of their long-standing strategic partnership, aimed at revolutionizing healthcare delivery through the use of advanced technology and innovative solutions. Building on a successful collaboration that has spanned over a decade, this new agreement will extend the partnership for an additional five years, with the option for further extension.

Philips, a global leader in health technology, will continue to support Isala Hospital in optimizing healthcare processes, particularly in the radiology and cardiology departments. The partnership is focused on ensuring that healthcare remains accessible, available, and affordable for patients. By integrating cutting-edge technology, data analytics, and artificial intelligence into hospital operations, the two organizations aim to improve patient outcomes and enhance the efficiency of care delivery.

Isala Hospital will utilize Philips’ technology to not only modernize its medical systems, such as MRI and CT scanners, but also to implement a flexible, multi-year replacement plan. This plan is designed to be both cost-effective and sustainable, ensuring that the hospital’s equipment remains state-of-the-art. The continuous updates and improvements will extend the lifespan of the systems, delivering financial and environmental benefits.

Jules de Vet, a member of the Board of Directors at Isala, emphasized the importance of technology in maintaining high standards of care, stating, “Our focus is on maintaining accessible, available, and affordable care in a cost-effective way; the right technology plays a crucial role in this.”

Léon Kempeneers, Managing Director at Philips Benelux, highlighted the challenges faced by hospitals in the coming years, particularly in terms of financial constraints and personnel shortages. He noted that the renewed partnership with Isala would focus on enhancing the clinical adoption of new technologies, including AI, to simplify the work of healthcare providers and improve patient care.

This partnership renewal is a testament to the shared commitment of Philips and Isala to drive innovation in healthcare and ensure the delivery of sustainable, high-quality care to patients.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 68,700 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Media Contacts:

Joost Maltha
Philips External Relations
Tel: +31610558116
joost.maltha@philips.com

Pieter de Meer
PR & Communications Manager Health Systems Benelux
Tel: +31625269065
pieter.de.meer@philips.com

SOURCE: Philips

Follow EuropaWire on Google News
EDITOR'S PICK:

Comments are closed.